HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 2007-0653v1 26/2/570    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Arnalich-Montiel, F. Articles by De Miguel, M. P. Search for Related Content PubMed PubMed Citation Articles by Arnalich-Montiel, F. Articles by De Miguel, M. P.

TRANSLATIONAL AND CLINICAL RESEARCH

Adipose-Derived Stem Cells Are a Source for Cell Therapy of the Corneal Stroma

^aCell Engineering Laboratory,
^cPlastic and Reconstructive Surgery Department, and
^dPathology Department, La Paz University Hospital, Madrid, Spain;
^bVissum Ophthalmological Institute of Alicante and Miguel Hernandez University, Alicante, Spain

Key Words. Cornea • Cell therapy • Adipose-derived stem cells • Mesenchymal stem cells • Transplant • Keratocan Stem cell transplantation • Keratocyte

Correspondence: Correspondence: Maria P. De Miguel, Ph.D., Cell Engineering Laboratory, La Paz University Hospital, Maternity Building, Paseo Castellana 261, Madrid 28046. Spain. Telephone: 34-91-2071458; Fax: 34-91-7277050; e-mail: maria.demiguel{at}uam.es

Received on August 7, 2007; accepted for publication on November 27, 2007.

First published online in STEM CELLS EXPRESS  December 6, 2007.


Most corneal diseases affect corneal stroma and include immune or infectious diseases, ecstatic disorders, traumatic scars, and corneal dystrophies. Cell-based therapy is a promising therapeutic approach to overcome the current disadvantages of corneal transplantation. We intended to search for a cell source to repopulate and regenerate corneal stroma. We investigated the ability of human processed lipoaspirate derived (PLA) cells to regenerate corneal stroma in experimental animals. In the first set of experiments, we tested the biosafety and immunogenicity of human PLA stem cells transplanted into the corneal stroma of rabbits. No immune response was elicited even though we used immune-competent animals. PLA cells survived up to 10 weeks post-transplant, maintained their shape, and remained intermingled in the stroma without disrupting its histological pattern. Interestingly, transparency was preserved even 10 weeks after the transplant, when PLA cells formed a discontinuous layer in the stroma. In the second set of experiments, regeneration of the corneal stroma by PLA cells was assessed, creating a niche by partial ablation of the stroma. After 12 weeks, human cells were disposed following a multilayered pattern and differentiated into functional keratocytes, as assessed by the expression of aldehyde-3-dehydrogenase and cornea-specific proteoglycan keratocan. Based on our results, we believe that adipose-derived adult stem cells can be a cell source for stromal regeneration and repopulation in diseased corneas. The low health impact of the surgical procedure performed to obtain the PLA cells provides this cell source with an additional beneficial feature for its possible future autologous use in human patients.

Disclosure of potential conflicts of interest is found at the end of this article.